Cite

HARVARD Citation

    Gray, E. et al. (n.d.). 617 Tisotumab vedotin shows immunomodulatory activity through induction of immunogenic cell death. Journal for immunotherapy of cancer. p. A653. [Online]. 
  
Back to record